Inspire Medical Systems Inc at JPMorgan Healthcare Conference (Virtual) Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Oh, great. There's a lot I want to get to, but I want to ask one question that came in from the audience that I think kind of ties into some of the advertising. This is -- how does the captive call center help in directing patients towards its doctors, who do Inspire therapy. Can you build upon more of the marketing and direct-to-consumer advertising to help drive and convert the patients who are aware but don't get it? And the doctors who don't currently offer it, but absolutely could.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : I mean I'll tell you, I've called to make specialist appointments, and it's 2, 3 months out sometime. So I totally get it. So let's talk about the current trends. You put out the other day and you reiterated in the slides that we're reiterating our guidance for fourth quarter. And I definitely had some investors come to me saying this is -- look, Inspire has a long history of beating their guidance and just reiterating here is a negative. I just want to let you in your own words say, is that the way to interpret it? Or is it more just you feel comfortable putting the guidance out again that you gave on the third quarter call, and it's not implying anything to the negative?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : And I apologized, Rick, I didn't introduce you when we started Q&A here. Rick is the CFO, as most of you know. So who was it that put 3 exclamation points on the 2021? And is that a reflection of how excited you are for 2021?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Well, I guess that's one of the benefits of just picking up coverage. A few months ago, I got to sidestep all the insurance coverage and started the good part.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Right. So let's talk about that, right? Because you do have some new codes in place, insurance coverage is not really an issue at all anymore. How does that change the discussion when you go into a doctor's office, when they're talking to a patient? And how much less -- how does eliminating the reimbursement friction help drive sales to Inspire?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : So looking at a few years out, Inspire V is in the works. Where do you stand on this device? Do you think that's what's needed to drive more penetration in the market? Can you do it with the current version? And really, just remind us what in the Inspire V is so different from what you have today? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JANUARY 13, 2021 / 8:40PM, INSP.N - Inspire Medical Systems Inc at JPMorgan Healthcare Conference (Virtual)

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Is there any risk around lower revenues when you -- for the doctors when they don't implant the sensing lead? And how does that play into the new reimbursement?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Got it. Tim, a question from the audience. How do we think about the ASC pipeline for Inspire?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Great. Well, we just have a minute or 2 left here, and I've got a couple of questions that just came in, going to pick and choose here in the time left. Tim, why did Anthem not accept coverage this time around? And is it something you expect could happen in the future?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Got it. Well, I apologize. There's a handful of questions here. I didn't get to, that came in late. Feel free to reach out to me if you still want to discuss. And Tim and Rick, thank you so much for joining us today. I really appreciate it. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JANUARY 13, 2021 / 8:40PM, INSP.N - Inspire Medical Systems Inc at JPMorgan Healthcare Conference (Virtual)

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Yes, in person, no COVID. Thanks, everyone. Have a great evening.